Analyst Ratings for Trillium Therapeutics (TRIL)

TRIL Rating Summary

  |   Expand Research on TRIL
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/17/2021 Benchmark Aydin Huseynov Downgrade Hold
(Buy)		 N/A
(N/A)		 18.44
(19.86)		 7.7% Details
8/24/2021 Craig-Hallum Robert Garner Downgrade Hold
(Buy)		 N/A
(N/A)		 17.59
(19.86)		 12.91% Details